39 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
or cause to be paid all costs and expenses actually incurred and incident to the performance of its obligations hereunder, including without limitation … , (i) the costs incident to the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection
8-K
EX-3.1
7je4t21fye8v1v55xfyt
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-10.1
wn0p8cdmbv3v
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
S-3ASR
EX-1.2
37zsbx
4 Aug 21
Automatic shelf registration
4:11pm